Home › Macular Degeneration › Texas › McAllen
Macular Degeneration clinical trials in McAllen, TX
6 studies for Macular Degeneration are looking for participants at sites in and around McAllen (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RecruitingPhase 1/2
- Valley Retina Institute, PA, McAllen
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Valley Retina Institute, P.A., McAllen
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Valley Retina Institute, P.A., McAllen
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
RecruitingPhase 1/2
- Valley Retina Institute, PA, McAllen
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
RecruitingPhase 1/2
- McAllen, TX, McAllen
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
RecruitingObservational studyHealthy volunteers welcome
- Valley Retina Institute, McAllen
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Sacramento, CA8 studies
- Hagerstown, MD8 studies
- Reno, NV8 studies
- Phoenix, AZ7 studies
- Cleveland, OH7 studies
- Houston, TX7 studies
- Salt Lake City, UT7 studies
- Boston, MA7 studies
- Austin, TX7 studies
Other studies in McAllen
- Metastatic Cancer5 studies
- Breast Cancer4 studies
- Atherosclerosis4 studies
- Heart Failure3 studies
- Obesity3 studies
- Cardiovascular Disease3 studies
- Geographic Atrophy3 studies
- Diabetic Foot3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.